you are here: Home News Dr Reddys Labs

Dr Reddys Labs

Neutral Dr Reddys Labs; target of Rs 1250: Motilal Oswal
Dr Reddys Labs Consolidated September 2025 Net Sales at Rs 8,828.30 crore, up 9.83% Y-o-Y
Dr Reddys Labs Standalone September 2025 Net Sales at Rs 4,618.60 crore, down 31.03% Y-o-Y
Neutral Dr Reddys Labs; target of Rs 1250: Motilal Oswal
Neutral Dr Reddys Labs; target of Rs 1190: Motilal Oswal
Dr Reddys Labs Standalone June 2025 Net Sales at Rs 7,809.50 crore, up 33.7% Y-o-Y
Dr Reddys Labs Standalone March 2025 Net Sales at Rs 5,562.90 crore, up 8.97% Y-o-Y
Dr Reddys Labs Consolidated March 2025 Net Sales at Rs 8,528.40 crore, up 19.89% Y-o-Y
Dr Reddy's Labs Q4 Results: Net profit rises 22% to Rs 1,594 crore on strong generics, NRT boost, beats estimates
Dr Reddys Labs Consolidated December 2024 Net Sales at Rs 8,381.20 crore, up 15.81% Y-o-Y
Neutral Dr Reddys Labs; target of Rs 1330: Motilal Oswal
Dr Reddys Labs Standalone December 2024 Net Sales at Rs 5,015.00 crore, up 22.23% Y-o-Y
Dr Reddy's surges 4% on Nuvama upgrade to 'buy', bullishness on efforts to mitigate Revlimid expiry impact
Dr Reddy's Labs top Nifty gainer, surges 9% in three sessions
Dr Reddy's launches cancer drug Toripalimab in India
Gainers & Losers: Stocks and sectors that moved the most on November 6
Dr Reddys Labs Consolidated September 2024 Net Sales at Rs 8,038.20 crore, up 16.45% Y-o-Y
Dr Reddys Labs Standalone September 2024 Net Sales at Rs 6,696.30 crore, up 38.39% Y-o-Y
Lack of strong launch pipeline keep brokerages neutral over Dr Reddy's Labs
Dr Reddys Labs Consolidated June 2024 Net Sales at Rs 7,696.10 crore, up 13.88% Y-o-Y
Dr Reddys Labs Standalone June 2024 Net Sales at Rs 5,841.20 crore, up 7.43% Y-o-Y
Dr Reddys Labs Standalone March 2024 Net Sales at Rs 5,104.80 crore, up 12.09% Y-o-Y
Neutral Dr Reddy’s Labs; target of Rs 6,070: Motilal Oswal
Dr Reddy's Labs CFO Parag Agarwal to retire on July 31, MV Narasimham elevated
What’s after Revlimid for Dr Reddy’s, Cipla, and Sun Pharma?

English

Markets

News

Personal Finance

Mutual Funds

Commodities

Media

Invest Now

Specials

Dr Reddys Labs

Neutral Dr Reddys Labs; target of Rs 1250: Motilal Oswal

Dr Reddys Labs Consolidated September 2025 Net Sales at Rs 8,828.30 crore, up 9.83% Y-o-Y

Dr Reddys Labs Standalone September 2025 Net Sales at Rs 4,618.60 crore, down 31.03% Y-o-Y

Neutral Dr Reddys Labs; target of Rs 1250: Motilal Oswal

Neutral Dr Reddys Labs; target of Rs 1190: Motilal Oswal

Dr Reddys Labs Standalone June 2025 Net Sales at Rs 7,809.50 crore, up 33.7% Y-o-Y

Dr Reddys Labs Standalone March 2025 Net Sales at Rs 5,562.90 crore, up 8.97% Y-o-Y

Dr Reddys Labs Consolidated March 2025 Net Sales at Rs 8,528.40 crore, up 19.89% Y-o-Y

Dr Reddy's Labs Q4 Results: Net profit rises 22% to Rs 1,594 crore on strong generics, NRT boost, beats estimates

Dr Reddys Labs Consolidated December 2024 Net Sales at Rs 8,381.20 crore, up 15.81% Y-o-Y

Neutral Dr Reddys Labs; target of Rs 1330: Motilal Oswal

Dr Reddys Labs Standalone December 2024 Net Sales at Rs 5,015.00 crore, up 22.23% Y-o-Y

Dr Reddy's surges 4% on Nuvama upgrade to 'buy', bullishness on efforts to mitigate Revlimid expiry impact

Dr Reddy's Labs top Nifty gainer, surges 9% in three sessions

Dr Reddy's launches cancer drug Toripalimab in India

Gainers & Losers: Stocks and sectors that moved the most on November 6

Dr Reddys Labs Consolidated September 2024 Net Sales at Rs 8,038.20 crore, up 16.45% Y-o-Y

Dr Reddys Labs Standalone September 2024 Net Sales at Rs 6,696.30 crore, up 38.39% Y-o-Y

Lack of strong launch pipeline keep brokerages neutral over Dr Reddy's Labs

Dr Reddys Labs Consolidated June 2024 Net Sales at Rs 7,696.10 crore, up 13.88% Y-o-Y

Dr Reddys Labs Standalone June 2024 Net Sales at Rs 5,841.20 crore, up 7.43% Y-o-Y

Dr Reddys Labs Standalone March 2024 Net Sales at Rs 5,104.80 crore, up 12.09% Y-o-Y

Neutral Dr Reddy’s Labs; target of Rs 6,070: Motilal Oswal

Dr Reddy's Labs CFO Parag Agarwal to retire on July 31, MV Narasimham elevated

What’s after Revlimid for Dr Reddy’s, Cipla, and Sun Pharma?